49
Participants
Start Date
November 21, 2016
Primary Completion Date
July 21, 2017
Study Completion Date
July 21, 2017
SyB P-1501
"After extubation and adequate titration by Fentanyl intravenous injection, the investigational product is applied to outer upper arm or chest on patient who confirmed treatment eligibility. Fentanyl 40 μg per dose is delivered over a 10-minute period by pressing the dosing button by the subject as needed. The 10-minute dosing period is a system lock-out time, allowing for a maximum of 6 doses per hour. One system is operable for 24 hours or until 80 doses are delivered, whichever occurs first.~Duration of application of the investigational product is 24 hours. Duration of application may be extended for up to 72 hours or until the third system is used, whichever occurs first, if the patient requests it and the specified tests can be performed"
SyB P-1501 placebo
Identical to SyB P-1501 containing hydrogel that contains the active ingredient fentanyl HCI in its structure and appearance but production of an electric current and subsequent drug administration by iontophoresis are prevented because of its modified circuit.
Research Site, Nagakute
Research Site, Nagoya
Research Site, Toyoake
Research Site, Kobe
Research Site, Kahoku
Research Site, Kanazawa
Research Site, Hiragi
Research Site, Nankoku
Research Site, Sendai
Research Site, Matsumoto
Research Site, Kashihara
Research Site, Kurashiki
Research Site, Sayama
Research Site, Suita
Research Site, Takatsuki
Research Site, Izumo
Research Site, Arakawa City
Research Site, Minato
Research Site, Yonago
Research Site, Ube
Research Site, Chūō
Research Site, Fukuoka
Research Site, Fukushima
Research Site, Kagoshima
Research Site, Kyoto
Research Site, Okayama
Research Site, Saga
Research Site, Tokushima
Research Site, Wakayama
Lead Sponsor
SymBio Pharmaceuticals
INDUSTRY